ADGRE5
ADGRE5 (adhesion G protein-coupled receptor E5, also known as CD97 or TM7LN1) is a member of the EGF-TM7 subfamily of adhesion G protein-coupled receptors. It is thought to act in adhesion and signalling early after leukocyte activation and contributes to leukocyte migration. Browse Assay Genie's current range of ADGRE5 research reagents below, or read on for the biology behind the target.
ADGRE5 is a receptor potentially involved in both adhesion and signalling processes early after leukocyte activation, and it plays an essential role in leukocyte migration. The NCBI Gene summary describes a role in cell adhesion as well as in leukocyte recruitment, activation and migration. Adhesion G protein-coupled receptors of this kind mediate cell-cell interactions.
The protein is cleaved by self-catalytic proteolysis into a large extracellular subunit and a seven-span transmembrane subunit. The two subunits associate at the cell surface as a receptor complex. The extracellular region contains multiple EGF-like repeats, which mediate binding to chondroitin sulfate and to the cell surface complement regulatory protein CD55. UniProt records the protein at the cell membrane and also in the extracellular space. The ADGRE5 gene produces alternatively spliced transcript variants that encode isoforms with 3 to 5 EGF-like repeats.
ADGRE5 belongs to the G protein-coupled receptor 2 family, LN-TM7 subfamily, and is classed by HGNC in adhesion G protein-coupled receptors subfamily E and among the CD molecules. It was previously named CD97 antigen and CD97 molecule. The gene lies in a cluster with other EGF-TM7 genes on the short arm of chromosome 19, and the related ADGRE1 and ADGRE2 belong to the same subfamily. Expression of the ADGRE5 gene may play a role in the progression of several types of cancer. The mouse ortholog is Adgre5.
ADGRE5 plays an essential role in leukocyte migration, making it a relevant target for studying how immune cells are recruited.
The receptor is potentially involved in adhesion and signalling early after leukocyte activation, relevant to studies of early activation events.
Expression of the ADGRE5 gene may play a role in the progression of several types of cancer, prompting expression studies.
Its EGF-like repeats bind chondroitin sulfate and CD55, so ADGRE5 is used to study receptor-ligand interactions in cell-cell adhesion.
ADGRE5 is a receptor potentially involved in adhesion and signalling early after leukocyte activation, and it plays an essential role in leukocyte migration. Its EGF-like repeats bind chondroitin sulfate and CD55, which supports a role in cell-cell interactions and leukocyte recruitment.
Yes. CD97 is a previous symbol for ADGRE5, and TM7LN1 is another alias. HGNC also lists the previous names CD97 antigen and CD97 molecule. Alternative splicing gives isoforms with 3 to 5 EGF-like repeats, so literature on CD97 usually applies to this gene.
The mouse ortholog is Adgre5. The NCBI Gene summary states that expression of this gene may play a role in the progression of several types of cancer. Check the datasheet of any product for its validated reactivity.
Other subfamily E adhesion G protein-coupled receptors that sit alongside ADGRE5 in the EGF-TM7 cluster.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P48960; product specifications from Assay Genie datasheets.